Acrivon Therapeutics, Inc.
ACRV
$2.37
-$0.04-1.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 129.25M | 137.42M | 149.64M | 179.48M | 187.45M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.11M | 989.00K | 1.69M | 2.15M | 1.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 130.36M | 138.41M | 151.33M | 181.63M | 188.98M |
|
|
|||||
| Total Current Assets | 130.36M | 138.41M | 151.33M | 181.63M | 188.98M |
| Net Property, Plant & Equipment | 7.98M | 8.12M | 7.98M | 8.03M | 8.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.85M | 1.85M | 1.85M | 1.85M | 1.84M |
| Total Assets | 145.30M | 158.58M | 176.35M | 196.59M | 214.68M |
|
|
|||||
| Total Accounts Payable | 996.00K | 1.16M | 3.69M | 758.00K | 1.51M |
| Total Accrued Expenses | 12.71M | 10.56M | 8.40M | 15.40M | 12.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.18M | 1.15M | 1.11M | 1.06M | 1.04M |
| Total Finance Division Other Current Liabilities | -- | 565.00K | 351.00K | -- | 54.00K |
| Total Other Current Liabilities | -- | 565.00K | 351.00K | -- | 54.00K |
| Total Current Liabilities | 14.89M | 13.43M | 13.55M | 17.21M | 14.82M |
|
|
|||||
| Total Current Liabilities | 14.89M | 13.43M | 13.55M | 17.21M | 14.82M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.81M | 2.12M | 2.41M | 2.59M | 2.97M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.70M | 15.55M | 15.96M | 19.80M | 17.79M |
|
|
|||||
| Common Stock & APIC | 384.39M | 380.59M | 376.76M | 373.32M | 370.26M |
| Retained Earnings | -255.90M | -237.66M | -216.66M | -196.98M | -174.15M |
| Treasury Stock & Other | 112.00K | 106.00K | 283.00K | 447.00K | 782.00K |
| Total Common Equity | 128.60M | 143.04M | 160.39M | 176.79M | 196.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 128.60M | 143.04M | 160.39M | 176.79M | 196.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 128.60M | 143.04M | 160.39M | 176.79M | 196.89M |
|
|
|||||